Literature DB >> 6083651

Marker substances and prostate cancer.

P R Huber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6083651     DOI： 10.1007/bf00256145

Source DB:  PubMed          Journal:  Urol Res        ISSN： 0300-5623


× No keyword cloud information.
  7 in total

Review 1.  Biological markers in prostate cancer.

Authors:  J E Pontes
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

2.  Immunological and clinical specificity of the immunochemical determination of prostatic acid phosphatase.

Authors:  L M Shaw; N Yang; M Neat; W Croop
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

3.  A prostate antigen in sera of prostatic cancer patients.

Authors:  L D Papsidero; M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

4.  Measurement of prostatic acid phosphatase in serum and bone marrow: radioimmunoassay and enzymic measurement compared.

Authors:  P R Huber; A Scholer; E Linder; V Hagmaier; H Vogt; P Christen; U Eppenberger; G Rutishauser
Journal:  Clin Chem       Date:  1982-10       Impact factor: 8.327

5.  Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.

Authors:  M Kuriyama; M C Wang; C L Lee; C S Killian; L D Papsidero; H Inaji; R M Loor; M F Lin; T Nishiura; N H Slack; G P Murphy; T M Chu
Journal:  J Natl Cancer Inst       Date:  1982-01       Impact factor: 13.506

6.  Tissue polypeptide antigen (TPA) and prostatic acid phosphatase in serum of prostatic cancer patients.

Authors:  P R Huber; M Rist; F Hering; C Biedermann; G Rutishauser
Journal:  Urol Res       Date:  1983

7.  Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer.

Authors:  P R Huber; T Zaugg; E Linder; V Hagmaier; G Rutishauser
Journal:  Urol Res       Date:  1982
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.